Single Cell Analysis Market: By Product Type (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization, Others), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Single Cell Analysis Market size was valued at USD 4,858.9 million in 2022 and  is expected to grow at a CAGR of 14.3% from 2023 to 2029. Single cell analysis is the study of genomics, proteomics, transcriptomics, metabolomics, and cell interactions at the single level. The increasing prevalence of cancer patients across the globe is expected to increase the demand for single cell analysis market over the forecast period. For instance, according to GLOBOCAN about 10 million deaths has been recorded due to cancer in 2020, and the number of cases is anticipated to increase from 19.3 million to 30 million cases by 2040. In addition, rising investments in research and development in clinical diagnostics, increasing availability of advanced technologies like sequencing, and increasing adoption of single cell analysis in molecular biology research are some factors expected to drive the single cell analysis market over the forecast period. In addition, the increasing research and development in pharmaceutical biotechnology industries, increasing focus on personalized medicines, and the growth of stem cells research is expected to further boost the growth of single cell analysis market over the forecast years. For instance, the COVID 19 breakout in 2020 had a positive impact on the single cell analysis market by its application in diagnostic of the virus and in the development of vaccines, thus, this factor raised the demand for global single cell analysis market. However, the high cost of single cell analysis products and lack of skilled professionals in performing single cell analysis procedure is expected to hold the growth of single cell analysis market. Moreover, increasing growth potential of single cell sequencing is anticipated to provide growth opportunities to key market players in single cell analysis market. Geographically, North America region held the major market share in 2022 and is expected to dominate the global single cell analysis market in the forecast years.

Single Cell Analysis Market
Key Developments:

In March 2021, Beckman Coulter Life Sciences Launched their next Gen CytoFLEX SRT Benchtop Cell Sorter which helps to display technology to automate, simplify and stream maintenance.

In November 2019, Qiagen Launched QiaSeq Multimodal Panels for the preparation of DNA and RNA libraries. 

Single Cell Analysis Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Single Cell Analysis Market Dynamics Dynamics

Single cell analysis market is expected to grow over the forecast period due to the increasing prevalence of cancer patients across the globe. The single cell analysis has been proved to be effective in the prior diagnosis of cancel cells. According to a research study by GLOBOCAN the risk of developing cancer has become high in adults. And the study says that about 10 million patients have died due to cancer and it is estimated that by 2040 the number of cancer patients will increased to 30 million. In addition, the growing investment in research and development by pharmaceutical and biotechnological companies in disease diagnosis and drug developments by the application of single cell analysis is expected to boost the market growth over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Single Cell Analysis Market Segmentation

By Product Type
  • Consumables
  • Instruments
By Technique
  • Flow Cytometry
  • Next Generation Sequencing
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Others
By Application
  • Oncology
  • Immunology
  • Neurology
  • Stem cell
  • Non-Invasive Prenatal Diagnosis
  • In-Vitro Fertilization
  • Others
By End User
  • Academic and Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Others

Frequently Asked Questions

Single Cell Analysis market was valued at USD 4,858.9 million in 2022, and is expected to grow at a 14.3% CAGR from 2023 to 2029.

North America Region is expected to have largest market share value in single cell analysis market over the forecast period.

The leading players in the global Single Cell Analysis market are Agilent technologies, Nanostring technologies, Luminex Corporation, Takara Bio, Fluxion Biosciences, QIAGEN NV, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Fluidigm Corporation, Beckman Coulter Life Sciences Inc.

  • Merck KGaA (Germany)
  • Danaher Corporation (U.S.)
  • Agilent Technologies (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • General Electric Company (U.K.)
  • Bio-Rad Laboratories, Inc.(U.S.)
  • Illumina, Inc. (U.S.)
  • NuGEN Technologies Inc. (U.S.)
  • 10x Genomics(U.S.)